Domenico Guajana

Country Commercial Senior Director at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Domenico Guajana's Colleagues at Alnylam Pharmaceuticals
Edoardo Baldi

Disease Awareness Specialist

Contact Edoardo Baldi

Andy Coppage

Associate Director, New Product Commercialization

Contact Andy Coppage

Claudia Cravesana

Senior Director Medical Affairs

Contact Claudia Cravesana

Andrea Havasi

Director, Medical Research

Contact Andrea Havasi

William Eliot

Vice President, General Manager Mid-Size Markets

Contact William Eliot

View All Domenico Guajana's Colleagues
Domenico Guajana's Contact Details
HQ
(617) 551-8200
Location
Milan,Lombardy,Italy
Company
Alnylam Pharmaceuticals
Domenico Guajana's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Domenico Guajana
Domenico Guajana currently works for Alnylam Pharmaceuticals.
Domenico Guajana's role at Alnylam Pharmaceuticals is Country Commercial Senior Director.
Domenico Guajana's email address is ***@alnylam.com. To view Domenico Guajana's full email address, please signup to ConnectPlex.
Domenico Guajana works in the SaaS industry.
Domenico Guajana's colleagues at Alnylam Pharmaceuticals are Edoardo Baldi, Vittorio Ricci, Andy Coppage, Tom Callanan, Claudia Cravesana, Andrea Havasi, William Eliot and others.
Domenico Guajana's phone number is (617) 551-8200
See more information about Domenico Guajana